SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
-12.67%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$502M
AUM Growth
+$502M
(-17%)
Cap. Flow
+$32.3M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
70.59%
Holding
49
New
3
Increased
5
Reduced
9
Closed
–
Top Buys
| 1 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$19.8M |
| 2 |
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
|
$11.2M |
| 3 |
IO Biotech
IOBT
|
$7.17M |
| 4 |
LENZ
LENZ Therapeutics
LENZ
|
$5.22M |
| 5 |
vTv Therapeutics
VTVT
|
$1.63M |
Top Sells
| 1 |
Recursion Pharmaceuticals
RXRX
|
$3.66M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$3.35M |
| 3 |
Instil Bio
TIL
|
$2.63M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$1.83M |
| 5 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$876K |
Sector Composition
| 1 | Healthcare | 98.43% |
| 2 | Financials | 1.57% |
